iShares Global Healthcare ETF (IXJ)
107.94
-0.62 -0.57%
NYSE Arca
Aug 23, 16:59
Delayed 2m
USD
IXJ Key Stats
| Expense Ratio | 0.48% |
| Share Class Assets Under Management | 1.554B |
| 30-Day Average Daily Volume | Upgrade |
| Net Asset Value | 108.42 |
| Discount or Premium to NAV | -0.08% |
| Turnover Ratio | 5.00 |
View All IXJ News
IXJ News
-
WireHeadlineTime (ET)
-
Yahoo08/23 09:07
-
SA Breaking News08/10 11:48
-
Yahoo07/26 15:09
-
SA Breaking News07/25 11:06
-
Yahoo07/25 07:37
-
SA Breaking News07/19 11:15
-
Yahoo07/18 10:37
-
Yahoo07/17 10:37
-
SA Breaking News07/13 13:30
-
SA Breaking News07/12 15:12
IXJ Performance
| Total Return | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|
| 1M | -3.07% | -3.61% | 8 |
| 3M | 2.13% | 4.31% | 69 |
| 6M | 6.68% | 7.49% | 55 |
| 1Y | 5.56% | 8.58% | 68 |
| 3Y | 5.92% | 7.86% | 63 |
| 5Y | 13.82% | 16.94% | 83 |
| 10Y | 8.86% | 11.48% | 87 |
IXJ Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.47% | 0.47% | 0.00 |
| Stock | 99.53% | 99.53% | 0.00 |
| Bond | 0.00 | 0.00 | 0.00 |
| Convertible | 0.00 | 0.00 | 0.00 |
| Preferred | 0.00 | 0.00 | 0.00 |
| Other | 0.00 | 0.00 | 0.00 |
IXJ Region Exposure
| Americas | 69.91% |
| North America | 69.91% |
| Latin America | 0.00 |
| Greater Europe | 23.56% |
| United Kingdom | 4.19% |
| Europe Developed | 19.37% |
| Europe Emerging | 0.00 |
| Africa/Middle East | 0.00 |
| Greater Asia | 6.53% |
| Japan | 4.97% |
| Australasia | 1.56% |
| Asia Developed | 0.00 |
| Asia Emerging | 0.00 |
| Market Classification | |
| % Developed Markets | 100.00% |
| % Emerging Markets | 0.00 |
IXJ Stock Sector Exposure
| Basic Materials | 0.41% |
| Communication Services | 0.00 |
| Consumer Cyclical | 0.00 |
| Consumer Defensive | 0.00 |
| Energy | 0.00 |
| Financial Services | 0.00 |
| Healthcare | 98.63% |
| Industrials | 0.00 |
| Real Estate | 0.00 |
| Technology | 0.95% |
| Utilities | 0.00 |
IXJ Stock Market Capitalization
| Giant | 57.79% |
| Large | 35.92% |
| Medium | 6.23% |
| Small | 0.07% |
| Micro | 0.00 |
IXJ Stock Style Exposure
| Large Cap Value | 24.26% |
| Large Cap Blend | 37.29% |
| Large Cap Growth | 32.15% |
| Mid Cap Value | 1.11% |
| Mid Cap Blend | 2.21% |
| Mid Cap Growth | 2.91% |
| Small Cap Value | 0.00 |
| Small Cap Blend | 0.07% |
| Small Cap Growth | 0.00 |
View More Holdings
As of Aug. 22, 2017
IXJ Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 8.25% | 132.61 | -1.55% |
| NVSEF | Novartis AG | 4.98% | -- | -- |
| PFE | Pfizer Inc | 4.50% | 33.28 | +0.39% |
| UNH | UnitedHealth Group Inc | 4.27% | 194.32 | -0.24% |
| RHHVF | Roche Holding AG Dividend Right Cert. | 4.01% | -- | -- |
| MRK | Merck & Co Inc | 3.88% | 62.15 | -0.43% |
| AMGN | Amgen Inc | 2.85% | 169.01 | -0.62% |
| ABBV | AbbVie Inc | 2.60% | 71.51 | -0.33% |
| MDT | Medtronic PLC | 2.54% | 79.80 | -2.40% |
| SNYNF | Sanofi SA | 2.52% | -- | -- |
Advertisement
IXJ One Page Reports
- One Page Report Download
IXJ Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | iShares |
| Benchmark Index | |
|---|---|
S&P Global 1200 Healthcare Sector NR USD |
100.0% |
IXJ Manager Info
| Name | Tenure |
|---|---|
| Alan Mason | 1.29 yrs |
| Diane Hsiung | 9.59 yrs |
| Greg Savage | 9.59 yrs |
| Jennifer Hsui | 5.00 yrs |
IXJ Net Fund Flows
| 1M | 27.07M |
| 3M | 22.15M |
| 6M | 11.67M |
| YTD | 26.17M |
| 1Y | -160.37M |
| 3Y | 233.33M |
| 5Y | 468.01M |
| 10Y | 321.24M |
IXJ Risk Info
| Beta (5Y) | 0.9045 |
| Max Drawdown (All) | 42.81% |
| Historical Sharpe (10Y) | 0.6808 |
| Historical Sortino (All) | 0.6783 |
| 30-Day Rolling Volatility | 7.99% |
| Daily Value at Risk (VaR) 1% (All) | 3.00% |
| Monthly Value at Risk (VaR) 1% (All) | 11.75% |
IXJ Fundamentals
| Dividend Yield TTM (8-23-17) | 1.59% |
| SEC Yield (12-31-15) | 1.42% |
| Weighted Average PE Ratio | 24.13 |
| Weighted Average Price to Sales Ratio | 2.182 |
| Weighted Average Price to Book Ratio | 3.799 |
| Weighted Median ROE | 23.92% |
| Weighted Median ROA | 8.67% |
| Forecasted Dividend Yield | 2.10% |
| Forecasted PE Ratio | 21.04 |
| Forecasted Price to Sales Ratio | 2.045 |
| Forecasted Price to Book Ratio | 3.444 |
| Number of Holdings | 107 |
IXJ Growth Estimates
| Forecasted 5 Yr Earnings Growth | 8.74% |
| Forecasted Book Value Growth | 7.20% |
| Forecasted Cash Flow Growth | 9.38% |
| Forecasted Earnings Growth | 6.15% |
| Forecasted Revenue Growth | 8.57% |
IXJ Comparables
EditIXJ Attributes
| Key Dates | |
|---|---|
| Inception Date | 11/13/2001 |
| Last Annual Report Date | 3/31/2017 |
| Last Prospectus Date | 8/1/2017 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
IXJ Excel Add-In Codes
- Name: =YCI("IXJ","name")
- Broad Asset Class: =YCI("IXJ", "broad_asset_class")
- Broad Category: =YCI("IXJ", "broad_category_group")
- Prospectus Objective: =YCI("IXJ", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
